Timothy Sullivan Overview
- Company
- Apellis Pharmace...
- Primary Position
-
Chief Financial...
- Primary Industry
-
Healthcare
- Active Board Seats
-
1
- Med. Deal Size
-
- Med. Valuation
-
Timothy Sullivan General Information
Biography
Mr. Timothy Sullivan serves as Chief Financial Officer at Apellis. He serves as a Board Member at Allysta. He has served as our chief financial officer since October 2017. From January 2014 to October 2017, he served as a Partner at Aju IB Investment, a venture capital firm, at which he led the firm's investments in life sciences companies. Before joining Aju IB Investment, from December 2011 to January 2014, he was Managing Director and Head of life sciences investment banking at RBS Citizens. He was an observer on the board of directors from November 2014 until October 2017. He has previously served as a director of G1 Therapeutics and Molecular Templates. He received his MBA degree from the Columbia Business School and his BA degree in biology from Harvard University.
Contact Information
Address
- 6400 Westwind Way
- Suite A
- Crestwood, KY 40014
- United States
Timothy Sullivan Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Apellis Pharmaceuticals | Company | Chief Financial Officer, Finance & Treasurer, Finance | Waltham, MA | Drug Discovery |
Timothy Sullivan Board Seats (1)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Allysta | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Bellevue, WA |
Timothy Sullivan Lead Partner on Deals (2)
Timothy Sullivan has been the lead partner on 2 deals. Their latest deal was with Atea Pharmaceuticals, a drug discovery company. The deal was made for on 17-Sep-2014.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Atea Pharmaceuticals | 17-Sep-2014 | Early Stage VC (Series A) | Completed | Drug Discovery | Boston, MA | |
Molecular Templates | 15-Sep-2014 | Completed | Biotechnology | Austin, TX |
Timothy Sullivan Network (57)
Board Members (33)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Stephen Howard | Molecular Templates | Self | Austin, TX | |
Christy Shaffer Ph.D | G1 Therapeutics | Hatteras Venture Partners | Durham, NC | |
Molecular Templates | Self | Austin, TX | ||
Molecular Templates | Self | Austin, TX | ||
Allysta | Morningside Group | Bellevue, WA |
Portfolio Executives (24)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Jean-Pierre Sommadossi Ph.D | Atea Pharmaceuticals | Chief Executive Officer & Chairman | 17-Sep-2014 | Boston, MA |
Janet Hammond Ph.D | Atea Pharmaceuticals | Executive | 17-Sep-2014 | Boston, MA |
Atea Pharmaceuticals | Executive | 17-Sep-2014 | Boston, MA | |
Atea Pharmaceuticals | Chief Financial Officer, Finance & Executive Vice President | 17-Sep-2014 | Boston, MA | |
Atea Pharmaceuticals | Interim Chief Financial Officer | 17-Sep-2014 | Boston, MA |
Timothy Sullivan Affiliated Funds (1)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
IBK-AJU Star Seekers No.1 Private Equity Fund | AJU IB Investment | Buyout | Closed | 2012 |
Timothy Sullivan FAQs
-
Who is Timothy Sullivan?
Mr. Timothy Sullivan serves as Chief Financial Officer at Apellis.
-
How much does Timothy Sullivan typically invest?
Timothy Sullivan's median deal size is
. -
What is Timothy Sullivan’s main position?
Timothy Sullivan’s primary position is Chief Financial Officer, Finance & Treasurer, Finance.
-
How many active board seats does Timothy Sullivan hold?
Timothy Sullivan holds a board seat in Allysta.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »